| mRNA |
EKB-569 |
GDSC1000 |
pan-cancer |
AAC |
0.0026 |
0.9 |
| mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0029 |
0.9 |
| mRNA |
EHT 1864 |
GDSC1000 |
pan-cancer |
AAC |
-0.0026 |
0.9 |
| mRNA |
Y-39983 |
GDSC1000 |
pan-cancer |
AAC |
-0.0023 |
0.9 |
| mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0027 |
0.9 |
| mRNA |
neopeltolide |
CTRPv2 |
pan-cancer |
AAC |
0.0049 |
0.9 |
| mRNA |
GSK4112 |
CTRPv2 |
pan-cancer |
AAC |
-0.0024 |
1 |
| mRNA |
Vandetanib |
FIMM |
pan-cancer |
AAC |
-0.013 |
1 |
| mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
-0.0019 |
1 |
| mRNA |
BRD-K07442505 |
CTRPv2 |
pan-cancer |
AAC |
-0.0022 |
1 |